The threat of mosquito-borne outbreaks of emerging viruses will be tackled by the newly-established Research Group for Emerging Viruses, Inflammation and Therapeutics.
Researcher digs deeper into how virus is spread and suppressed by our wildlife.
Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment in the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus and Chikungunya Virus.
Some successful rheumatoid arthritis therapies may help us better understand how to treat people with mosquito-borne viral diseases.
Griffith University viral immunologist Professor Suresh Mahalingam has been appointed to a World Health Organization (WHO) advisory group tasked with combatting viruses like dengue and Zika.
Dr Lara Herrero, research leader at Griffith University’s Institute for Glycomics, has been honoured with the Creating Change Award at...
Scientists have discovered a way that could help treat severe inflammation from an infectious mosquito-borne disease during outbreaks. A team...
Griffith University and an international team of researchers have moved a step closer to identifying a broad spectrum treatment for the dreaded arthritogenic alphavirus infections.
Lara Herrero received the Prize for New Innovators in the 2023 Prime Minister’s Prizes for Science at a ceremony in Canberra last night.
Griffith University’s Institute for Glycomics celebrates the promotion of six of its researchers, in recognition of their outstanding contributions to...
